{"id":833982,"date":"2025-04-04T08:36:15","date_gmt":"2025-04-04T12:36:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/"},"modified":"2025-04-04T08:36:15","modified_gmt":"2025-04-04T12:36:15","slug":"opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/","title":{"rendered":"OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program"},"content":{"rendered":"
\n

MIAMI, April 04, 2025 (GLOBE NEWSWIRE) — OPKO<\/strong>Health,<\/strong>Inc.<\/strong>(NASDAQ:<\/strong>OPK)<\/strong> today announced that its Board of Directors has authorized an increase of $100 million to the Company\u2019s existing common stock repurchase program, bringing the aggregate capacity of the program to $200 million. Approximately $41 million of OPKO\u2019s common stock has been repurchased under the existing program since its authorization in July 2024.<\/p>\n

\u201cWe believe OPKO\u2019s shares continue to be significantly undervalued and offer an attractive investment opportunity. Buying back shares supports our conviction in OPKO\u2019s strategy as we continue to advance our pipeline in the clinic and streamline our diagnostic segment on a path to profitability,\u201d said Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO. \u201cOur strong cash position provides the ability to continue to fund our programs, while returning capital to our shareholders.\u201d<\/p>\n

OPKO intends to repurchase shares of its common stock from time to time through open market purchases, block trades, privately negotiated transactions, accelerated share repurchase transactions and\/or pursuant to Rule 10b5-1 plans, in compliance with applicable securities laws and other legal requirements. The timing and amount of any repurchases will be subject to general market conditions, as well as the Company\u2019s management of capital, other investment opportunities and other factors. The repurchase program does not obligate the Company to repurchase any specific number of shares, has no time limit and may be modified, suspended or discontinued at any time at the Company\u2019s discretion.<\/p>\n

OPKO currently expects to fund the repurchase program from existing cash and cash equivalents, and future cash flows. The Company had approximately 671.6 million shares outstanding as of February 24, 2025.\u00a0\u00a0 This increased authorization, along with the prior authorization, represents approximately 14% of shares outstanding at the current stock price.<\/p>\n

\n About<\/strong>
\n OPKO<\/strong>
\n Health<\/strong>\n <\/p>\n

OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise, and its novel and proprietary technologies. For more information, visit www.opko.com<\/u><\/a>.<\/p>\n

\n Cautionary<\/strong>
\n Statement<\/strong>
\n Regarding<\/strong>
\n Forward<\/strong>
\n Looking<\/strong>
\n Statements<\/strong>\n <\/p>\n

\n This<\/em>
\n press<\/em>
\n release<\/em>
\n contains<\/em>
\n \u201cforward-looking<\/em>
\n statements,\u201d<\/em>
\n as<\/em>
\n that<\/em>
\n term<\/em>
\n is<\/em>
\n defined<\/em>
\n under<\/em>
\n the<\/em>
\n Private<\/em>
\n Securities<\/em>
\n Litigation<\/em>
\n Reform<\/em>
\n Act<\/em>
\n of<\/em>
\n 1995<\/em>
\n (\u201cPSLRA\u201d),<\/em>
\n including,<\/em>
\n among<\/em>
\n other<\/em>
\n things,<\/em>
\n statements<\/em>
\n related<\/em>
\n to<\/em>
\n expected<\/em>
\n purchases<\/em>
\n under<\/em>
\n the<\/em>
\n Repurchase<\/em>
\n Program.<\/em>
\n These<\/em>
\n forward-<\/em>
\n looking<\/em>
\n statements<\/em>
\n may<\/em>
\n be<\/em>
\n identified<\/em>
\n by<\/em>
\n words<\/em>
\n such<\/em>
\n as<\/em>
\n \u201cexpects,\u201d<\/em>
\n \u201cplans,\u201d<\/em>
\n \u201cprojects,\u201d<\/em>
\n \u201cwill,\u201d<\/em>
\n \u201cmay,\u201d<\/em>
\n \u201canticipates,\u201d<\/em>
\n \u201cbelieves,\u201d<\/em>
\n \u201cshould,\u201d<\/em>
\n \u201cintends,\u201d<\/em>
\n \u201cestimates,\u201d<\/em>
\n and<\/em>
\n other<\/em>
\n words<\/em>
\n of<\/em>
\n similar<\/em>
\n meaning.<\/em>
\n These<\/em>
\n statements<\/em>
\n are<\/em>
\n based<\/em>
\n on<\/em>
\n management\u2019s<\/em>
\n current<\/em>
\n expectations<\/em>
\n and<\/em>
\n are subject<\/em>
\n to<\/em>
\n uncertainty<\/em>
\n and<\/em>
\n changes<\/em>
\n in<\/em>
\n circumstances.<\/em>
\n Many<\/em>
\n factors<\/em>
\n could<\/em>
\n cause<\/em>
\n the<\/em>
\n Company\u2019s<\/em>
\n actual<\/em>
\n activities<\/em>
\n or<\/em>
\n results<\/em>
\n to<\/em>
\n differ<\/em>
\n materially<\/em>
\n from<\/em>
\n the<\/em>
\n activities<\/em>
\n and<\/em>
\n results<\/em>
\n anticipated<\/em>
\n in<\/em>
\n forward-looking<\/em>
\n statements.<\/em>
\n These<\/em>
\n factors<\/em>
\n include<\/em>
\n those<\/em>
\n described<\/em>
\n in<\/em>
\n the<\/em>
\n Company\u2019s<\/em>
\n Annual<\/em>
\n Reports<\/em>
\n on<\/em>
\n Form<\/em>
\n 10-K<\/em>
\n filed<\/em>
\n and<\/em>
\n to<\/em>
\n be<\/em>
\n filed<\/em>
\n with<\/em>
\n the<\/em>
\n Securities<\/em>
\n and<\/em>
\n Exchange<\/em>
\n Commission<\/em>
\n and<\/em>
\n under<\/em>
\n the<\/em>
\n heading<\/em>
\n \u201cRisk<\/em>
\n Factors\u201d<\/em>
\n in<\/em>
\n the<\/em>
\n Company\u2019s<\/em>
\n other<\/em>
\n filings<\/em>
\n with<\/em>
\n the<\/em>
\n Securities<\/em>
\n and<\/em>
\n Exchange<\/em>
\n Commission.<\/em>
\n In<\/em>
\n addition,<\/em>
\n forward-looking<\/em>
\n statements<\/em>
\n may<\/em>
\n also<\/em>
\n be<\/em>
\n adversely<\/em>
\n affected<\/em>
\n by<\/em>
\n general<\/em>
\n market<\/em>
\n factors,<\/em>
\n competitive<\/em>
\n product<\/em>
\n development,<\/em>
\n product<\/em>
\n availability,<\/em>
\n federal<\/em>
\n and<\/em>
\n state<\/em>
\n regulations<\/em>
\n and<\/em>
\n legislation,<\/em>
\n the<\/em>
\n regulatory<\/em>
\n process<\/em>
\n for<\/em>
\n new<\/em>
\n products<\/em>
\n and<\/em>
\n indications,<\/em>
\n manufacturing<\/em>
\n issues<\/em>
\n that<\/em>
\n may<\/em>
\n arise,<\/em>
\n patent<\/em>
\n positions<\/em>
\n and<\/em>
\n litigation, among<\/em>
\n other factors. The<\/em>
\n forward-looking<\/em>
\n statements<\/em>
\n contained<\/em>
\n in<\/em>
\n this<\/em>
\n press<\/em>
\n release<\/em>
\n speak<\/em>
\n only<\/em>
\n as<\/em>
\n of<\/em>
\n the<\/em>
\n date<\/em>
\n the<\/em>
\n statements<\/em>
\n were<\/em>
\n made,<\/em>
\n and<\/em>
\n the<\/em>
\n Company<\/em>
\n does<\/em>
\n not<\/em>
\n undertake<\/em>
\n any<\/em>
\n obligation<\/em>
\n to<\/em>
\n update<\/em>
\n forward-looking<\/em>
\n statements.<\/em>
\n The<\/em>
\n Company<\/em>
\n intends<\/em>
\n that<\/em>
\n all<\/em>
\n forward-looking<\/em>
\n statements<\/em>
\n be<\/em>
\n subject<\/em>
\n to<\/em>
\n the<\/em>
\n safe-harbor<\/em>
\n provisions<\/em>
\n of<\/em>
\n the<\/em>
\n PSLRA.<\/em>\n <\/p>\n

\n
\n Contacts:<\/u>
\n <\/strong>\n <\/p>\n

\n Alliance Advisors IR<\/strong>
\n
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com<\/a>
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

MIAMI, April 04, 2025 (GLOBE NEWSWIRE) — OPKOHealth,Inc.(NASDAQ:OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company\u2019s existing common stock repurchase program, bringing the aggregate capacity of the program to $200 million. Approximately $41 million of OPKO\u2019s common stock has been repurchased under the existing program since its authorization in July 2024. \u201cWe believe OPKO\u2019s shares continue to be significantly undervalued and offer an attractive investment opportunity. Buying back shares supports our conviction in OPKO\u2019s strategy as we continue to advance our pipeline in the clinic and streamline our diagnostic segment on a path to profitability,\u201d said Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO. \u201cOur strong cash position provides … <\/p>\n

Continue reading “OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-833982","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nOPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MIAMI, April 04, 2025 (GLOBE NEWSWIRE) — OPKOHealth,Inc.(NASDAQ:OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company\u2019s existing common stock repurchase program, bringing the aggregate capacity of the program to $200 million. Approximately $41 million of OPKO\u2019s common stock has been repurchased under the existing program since its authorization in July 2024. \u201cWe believe OPKO\u2019s shares continue to be significantly undervalued and offer an attractive investment opportunity. Buying back shares supports our conviction in OPKO\u2019s strategy as we continue to advance our pipeline in the clinic and streamline our diagnostic segment on a path to profitability,\u201d said Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO. \u201cOur strong cash position provides … Continue reading "OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-04T12:36:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzA2MCM2ODUxNDMxIzIwMjU5NDE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program\",\"datePublished\":\"2025-04-04T12:36:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\\\/\"},\"wordCount\":603,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNzA2MCM2ODUxNDMxIzIwMjU5NDE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\\\/\",\"name\":\"OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNzA2MCM2ODUxNDMxIzIwMjU5NDE=\",\"datePublished\":\"2025-04-04T12:36:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNzA2MCM2ODUxNDMxIzIwMjU5NDE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNzA2MCM2ODUxNDMxIzIwMjU5NDE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/","og_locale":"en_US","og_type":"article","og_title":"OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - Market Newsdesk","og_description":"MIAMI, April 04, 2025 (GLOBE NEWSWIRE) — OPKOHealth,Inc.(NASDAQ:OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company\u2019s existing common stock repurchase program, bringing the aggregate capacity of the program to $200 million. Approximately $41 million of OPKO\u2019s common stock has been repurchased under the existing program since its authorization in July 2024. \u201cWe believe OPKO\u2019s shares continue to be significantly undervalued and offer an attractive investment opportunity. Buying back shares supports our conviction in OPKO\u2019s strategy as we continue to advance our pipeline in the clinic and streamline our diagnostic segment on a path to profitability,\u201d said Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO. \u201cOur strong cash position provides … Continue reading \"OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-04T12:36:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzA2MCM2ODUxNDMxIzIwMjU5NDE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program","datePublished":"2025-04-04T12:36:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/"},"wordCount":603,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzA2MCM2ODUxNDMxIzIwMjU5NDE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/","name":"OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzA2MCM2ODUxNDMxIzIwMjU5NDE=","datePublished":"2025-04-04T12:36:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzA2MCM2ODUxNDMxIzIwMjU5NDE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNzA2MCM2ODUxNDMxIzIwMjU5NDE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opko-health-announces-100-million-increase-to-its-existing-share-repurchase-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/833982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=833982"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/833982\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=833982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=833982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=833982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}